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ABSTRACT
Many studies have focused on the relationship between hearing loss and Alzheimer’s Disease (AD). The mechanisms and causal 
relationship of this association are still partially unknown, and several theories have been proposed. The most accredited hypothesis 
is that peripheral hearing deprivation may lead to social isolation and subsequently to dementia. Another hypothesis supports the 
role of hearing loss on cortical processing, with an increased assignment of cognitive resources to auditory processing rather than 
to other cognitive processes; other theories suggest changes in the brain structure following reduced peripheral auditory stimulation, 
or a common cause to both conditions. These preliminary findings clearly delineate the importance of further research aimed at 
investigating hearing impairment in AD, to a) allow early detection of people with predisposition to AD, b) improve the quality of 
life in AD patients with hearing loss and c) possibly prevent the progression of the disease treating the hearing impairment. In this 
review paper, the authors discuss current evidence on the association between hearing impairment and dementia, the identification 
of peripheral and central auditory dysfunction in at-risk patients as a potential early indicator of incipient AD, and the clinical aspects 
and the management of patients with AD and hearing loss.
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INTRODUCTION
Alzheimer’s Disease (AD) is an acquired condition 
characterized by progressive cognitive and behavioural 
decline and is the second most common form of dementia 
in the general population after mild cognitive impairment1. 
It is estimated that approximately 20 million people 
worldwide are affected from AD; however, only a portion 
of them is correctly diagnosed2-4. In the United States, 
around 5.5 million people have AD; of these, most (nearly 
5.3 million) are 65 year old and older while only 200.000 
have a young-onset form of AD5. The National Institute 
on Aging indicated that the prevalence of AD doubles 
every five years beyond the age of 656; therefore, as the 
population ages, AD impacts a greater percentage of 
people. It has been hypothesized that the total number of 
individuals with AD in the United States could increase to 
as high as 16 million by 20507,8. The correct identification 
of AD risk factors can be helpful in intercepting the 
disease and slowing its progression. At the moment, it 
is well known that age, family history, and biological 
inheritance are risk factors for AD4; however these factors 
cannot be modified and, thus, cannot contribute to 
reduce disease progression. The identification of other 
possibly modifiable risk factors may therefore help in the 
management of patients with AD. 
Aging is the most prevalent cause of sensorineural 
hearing loss9. The presence of hearing loss in the elderly is 
described by the term “presbycusis”; it typically presents 
as sensorineural hearing loss characterized by loss in 
the high frequencies10 (Figure 1) and sometimes may be 
associated to the presence of cochlear dead regions11. 
Presbycusis, the second most common health issue of 
the aged population after arthritis12, may present as a 
multifactorial hearing disorder characterized not only by 
general hearing disability, but also impaired recognition 
of words, especially in noisy environments, tinnitus and 
hyperacusis13-15. Recent studies have also suggested a 
role of synaptopathy between inner hair cells and sensory 
neurons in presbycusis16-18. 
The ability to communicate with friends and family 
mainly depends on one’s ability to hear and process 
speech and environmental sounds. When individuals 
develop presbycusis, they are hampered in their ability to 
converse by phone or face to face; these problems often 
have a significant impact on social life and may favor the 
onset of depression, cognitive decline and dementia19. 
Epidemiological studies have described an association 
between hearing loss and cognitive impairment including 
AD; other studies have shown that hearing disorders 
may be a potentially modifiable risk factor of AD20-25. In 
a review published in 2018, Swords et al.26 reported that 
both peripheral and central auditory system alterations 
can be found in early AD stages and they could be early 
indicators of the disease, thus suggesting to investigate 
peripheral and central auditory dysfunction in at-risk 
subjects as this could be an effective strategy to diagnose 
AD in its early stages and initiate therapeutic interventions 
aimed at enhancing the quality of life of AD patients and 
hopefully have a role in disease progression. 
These preliminary findings clearly delineate the 
importance of further research aimed at investigating 
hearing impairment in AD, to a) allow early detection of 
people with predisposition to AD, b) improve the quality 
of life in AD patients with hearing loss and c) possibly 
prevent the progression of the disease treating the 
hearing impairment.
ASSOCIATION BETWEEN HEARING LOSS AND 
ALZHEIMER’S DISEASE
Hearing loss and AD are common conditions in older 
adults with a significant impact on quality of life24-27. 
Epidemiological studies have demonstrated a correlation 
between these conditions and the role of hearing loss as 
a modifiable risk factor for the development of AD20-26. An 
Figure 1: Typical audiogram in presbycusis. Pure tone audiometry presents a sensorineural hearing loss characterized by loss in the high frequencies.
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observation study conducted by Uhlmann et al.28 in 1986 
on 156 patients with AD suggested hearing loss being 
an indicator for the development of cognitive dysfunction. 
A few years later, the same authors confirmed these 
preliminary findings reporting that hearing loss was 
significantly and independently correlated with the severity 
of cognitive dysfunction in an AD case-control study 
matched for age, sex, and education status29. Since then, 
several studies confirmed the association between AD 
and hearing impairment; however, the physiopathological 
mechanisms and causal relationship of this association 
remain unknown30. 
There are several theories that support the correlation 
between hearing loss and AD31. The most accredited 
hypothesis is that hearing impairment may lead to 
sensory deprivation and social isolation that subsequently 
leads to dementia32-35. Another theory suggests that 
hearing loss may affect cortical processing through the 
increase of the cognitive load and the assignment of 
cognitive resources to auditory processing rather than 
to other cognitive processes36-38. This hypothesis is also 
based on the evidence that auditory processing needs 
more cognitive resources when the auditory signal is 
deteriorated, thus resulting in the degradation of other 
cognitive processes39. Another theory proposes that 
decreased auditory stimulation causes changes in brain 
structure making the brain more vulnerable to factors 
able to cause brain pathologies, such as neurofibrillary 
tangles, Aβ accumulation, and micro-vascular disease, 
thus leading to a higher risk of dementia40. Other studies 
have speculated that there may be a common cause 
to both diseases and therefore hearing loss may be an 
early symptom of dementia; in fact, the auditory and the 
memory areas are strictly related and an atrophy in one of 
the two may impact on the other (Figure 2)26-42. 
Chang et al.43 attempted to discover the mechanisms 
underlying this association using animal models to 
elucidate the time course of cognitive decline following 
hearing loss and then evaluating changes in cognitive 
function and synaptic protein levels after induction of the 
hearing loss. They found that degeneration in the central 
auditory pathways may cause the degeneration of the 
synapses of hippocampus or increase the vulnerability of 
these synapses to damage. This hypothesis is supported 
by findings showing that focal cortical infarction of brain 
regions that are remote but connected to the hippocampus 
can induce neuronal loss in the hippocampus. 
Shen et al. have examined the involvement of a molecular 
pathway underlying the association between hearing 
loss and AD44. The authors summarized the enzymes 
and proteins that may have a role in the pathogenesis of 
both age-related hearing loss and AD and suggested that 
an abnormal expression of these structures, including 
Vascular Endothelial Growth Factor (VEGF), SIRT1-
PGC1α, and LKB1 (or CaMKKβ)-AMPK, may cause both 
AD and dysfunction of cochlear hair cells45-50. In addition, 
they hypothesized that these two conditions may also 
influence the progression of each other as they have 
common pathological pathways and targets. 
Although a large number of studies have investigated 
this relationship, there is still controversy about the role 
of peripheral hearing impairment and central auditory 
processing in AD. Peripheral hearing loss might have a 
more direct role on neurodegenerative processes at the 
base of dementia. In fact, hearing loss in older adults 
positively correlates with reduction of tissue volume 
in auditory cortex, temporal lobe, and the whole brain, 
and may lead to functional reorganization of auditory 
cortical networks20-32. The role of the central auditory 
processing in AD is still not well understood. Alterations 
in central auditory processing may reflect abnormal 
cortical mechanisms employed in the analysis of auditory 
scenes this is supported by the evidence that even minor 
alterations in auditory cortical evoked potentials can 
precede clinical symptoms of the neurological condition 
in young patients with pathogenic AD mutations19-54. 
A recent systematic review from Thomson et al.31 included 
17 articles that indicate an association between hearing 
Figure 2: Schematics of the brain structure. The temporal lobe (marked with red color) play an important role in organizing sensory input, auditory 
perception, language and speech production, as well as memory association and formation. 
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loss and dementia or cognitive decline, although a large 
variation in the methods used for ascertaining hearing 
loss and dementia was present in the included articles. 
Hearing loss was mainly evaluated through the peripheral 
auditory function with Pure Tone Audiometry (PTA), while 
only a fraction of the included studies measured central 
auditory function. Dementia was mainly defined using the 
Mini Mental State Exam (MMSE). The authors concluded 
that although they found a significant variability in the 
methods used to evaluate patients in the included studies, 
and they mainly evaluated peripheral hearing loss, each 
of them demonstrated that hearing loss was associated 
with higher incidence of dementia in older adults.
Results of other studies instead reported almost-normal 
pure tone thresholds in patients with AD, thus suggesting 
that AD pathology may be mainly associated with 
central, rather than peripheral, auditory dysfunction. 
Central auditory dysfunction should be suspected in 
subjects that report difficulties in understanding speech 
in background noise16. Gates et al.52 reported central 
auditory dysfunction as a prelude of AD performing 
central auditory processing tests in 274 elderly subjects 
with a mean age of 79.6 years and monitored them for a 
period of four years. The authors found that the results 
of central auditory processing tests were significantly 
worse in the patients that developed dementia during 
follow up and recommended to evaluate central auditory 
function in seniors complaining of hearing difficulty and in 
those specifically reporting difficulties in hearing in noise. 
Another study on patients in the Framingham dementia 
cohort55 found that severe central auditory dysfunction, 
based on low scores on the Synthetic Sentence 
Identification with Ipsilateral Competing Message test, 
could be an indicator of dementia diagnosis within 3 to 
12 years. In support of these hypotheses, a magnetic 
resonance brain image study by Lin et al.40 indicated that 
hearing loss is correlated with atrophy of the whole brain; 
such changes were more evident in the right temporal 
lobe.
CLINICAL FEATURES OF HEARING LOSS IN 
ALZHEIMER’S DISEASE
Hearing impairment in AD does not have specific 
characteristics that differentiate it from age-related 
hearing loss or from other forms of sensorineural hearing 
impairment; however, certain evidence suggests auditory 
cognitive disorders in AD19. It has been reported that 
patients with AD may experience more listening difficulties 
than expected from the degree of hearing loss diagnosed 
with PTA and may have a reduced benefit from the use of 
hearing aids56-59. Commonly, AD patients report difficulties 
in listening and in understanding the meaning of words 
in the presence of background noise; this contributes 
to the avoidance of social environments. However, this 
condition may also be present in otherwise healthy older 
adults with presbycusis60. Furthermore, patients with AD 
may have various abnormal behavioral responses to 
sounds, with an alteration in the mechanisms of matching 
sounds with past experiences61 leading to a poor or an 
aberrant perception of sounds. The first case constitutes 
an auditory agnosia, which consists in the impairment 
in sound perception and identification despite intact 
hearing, and may be limited to specific sounds, while 
the second may manifest as auditory hallucinations most 
probably deriving from aberrant cortical activity62. Last, 
hyperacusis - the intolerance to certain everyday sounds 
that cause significant distress and impairment in daily 
activities63,64 has been also reported in patients with AD65.
CLINICAL MANAGEMENT OF PATIENTS WITH 
ALZHEIMER’S DISEASE AND HEARING LOSS
A symptom-based clinical approach to patients 
presenting with cognitive impairment and hearing 
loss has been proposed by Hardy et al.19. The authors 
suggested that the assessment of hearing loss in patients 
with a neurological diagnosis of dementia, including 
AD, should initiate with clinical history evaluation to 
highlight key auditory symptoms, followed by a complete 
audiological and neurological examination. Audiological 
evaluation should include PTA, oto-acoustic emissions 
and brainstem auditory evoked potentials. Additional 
auditory tests, such as measurement of speech in noise 
perception, gap-in-noise perception, dichotic listening 
and tone-in noise audiometry66,67 can be used as they 
more closely reflects realistic hearing impairment and 
may indicate alterations in cortical auditory processing. 
At this regard, Rahman et al.68 evaluated central auditory 
processing in 150 patients with a neurological diagnosis 
of mild cognitive impairment and compared the results to 
150 age, sex and PTA-matched controls; the authors used 
selective auditory attention test, auditory fusion test, pitch 
pattern sequences test, and dichotic digits test and found 
a significant alteration of central auditory processing test 
scores in patients in the study group compared to those 
in the control group. 
General neuropsychological assessment should then be 
performed to identify executive or attention deficits that can 
also be present in these patients and may confound the 
results of auditory tests. Diagnosis should always include 
brain magnetic resonance imaging to exclude concurrent 
retrocochlear conditions i.e. vestibular schwannoma69,70 
and further characterize the neuroanatomical basis of the 
auditory deficit19. 
The management of patients with AD and hearing loss 
requires a multidisciplinary approach by audiologists, 
speech and language therapists, and neurologists and 
should include the immediate correction of any treatable 
cause of hearing impairment, such as the removal of 
earwax71,72, the use of hearing aids and other listening 
devices and specific strategies such as the employment 
of written communication and electronic devices, 
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the reduction of background noise, the avoidance of 
subjective distressing sounds and the use of competing 
techniques for auditory hallucinations73.
CONCLUSION
Much evidence has accumulated in the past decades on 
the association between hearing loss and AD; however the 
underlying mechanisms of this association remain partly 
unclear. Large-scale studies that employ on one side 
comprehensive peripheral and central hearing function 
evaluation and on the other a rigorous evaluation of AD 
diagnosis and brain magnetic resonance imaging are 
necessary to robustly assess the association of hearing 
impairment and AD. Furthermore, the understanding of 
the mechanisms underlying this association is still partial 
and requires specifically-aimed study protocols. 
Recent studies have shown a correlation between hearing 
loss and changes in brain structures of animal models 
that, together with changes in the molecular pathway at 
the base of these pathologies, could carry forward the 
future of research in this field. In fact, the identification of 
potentially common targets or pathways could allow the 
development of drugs aimed at this common target. On 
a clinical perspective, the correct identification of hearing 
loss in patients with AD is crucial, as its treatment has 
been shown to significantly improve the global condition 
of these patients. The management of patients with AD 
and hearing loss requires a multidisciplinary approach 
that should include audiologists, speech and language 
therapists, and neurologists.
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